Brussels, July 6 (RHC)-- The first drug to treat severe cases of COVID-19 in the European Union has been given the green light, with the European Commission approving remdesivir.
"We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus," Stella Kyriakides, the EU's health commissioner, said in a statement.
It is the first time the EU's executive arm has granted the approval to a COVID-19 drug and was the last step for remdesivir to be given the full the go-ahead.
